Cited by 53Treatment of Major DepressionNeurotransmitter Receptor Influence on BehaviorGenetics and Neurodevelopmental Disorders

Phosphorylation of MeCP2 at Ser421 Contributes to Chronic Antidepressant Action

Open access
Hutchinson, Ashley N., Deng, Jay V., Cohen, Sonia, West, Anne E.·2012·The Journal of Neuroscience

Abstract

Although tricyclic antidepressants rapidly activate monoaminergic neurotransmission, these drugs must be administered chronically to alleviate symptoms of depression. This observation suggests that molecular mechanisms downstream of monoamine receptor activation, which include the induction of gene transcription, underlie chronic antidepressant-induced changes in behavior. Here we show that methyl-CpG-binding protein 2 (MeCP2) regulates behavioral responses to chronic antidepressant treatment. Imipramine administration induces phosphorylation of MeCP2 at Ser421 (pMeCP2) selectively in the nucleus accumbens and the lateral habenula, two brain regions important for depressive-like behaviors. To test the role of pMeCP2 in depressive-like behaviors, we used male mice that bear a germ-line mutation knocked into the X-linked Mecp2 locus that changes Ser421 to a nonphosphorylatable Ala residue (S421A). MeCP2 S421A knock-in (KI) mice showed increased immobility in forced-swim and tail-suspension tests compared with their wild-type (WT) littermates. However, immobility of both MeCP2 WT and KI mice in forced swim was reduced by acute administration of imipramine, demonstrating that loss of pMeCP2 does not impair acute pharmacological sensitivity to this drug. After chronic social defeat stress, chronic administration of imipramine significantly improved social interaction in the MeCP2 WT mice. In contrast, the MeCP2 KI mice did not respond to chronic imipramine administration. These data suggest novel roles for pMeCP2 in the sensitivity to stressful stimuli and demonstrate that pMeCP2 is required for the effects of chronic imipramine on depressive-like behaviors induced by chronic social defeat stress.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.2156-12.2012

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • MeCP2 Ser421 phosphorylation is required for the long-lasting antidepressant effects of ketamine but not for the initial rapid antidepressant response.

    “While MeCP2 Ser421 phosphorylation is required for these long-lasting effects, it is not required for the initial rapid antidepressant response [78,80].”

    From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [80]

    The Discussion reports that MeCP2 Ser421 phosphorylation is required for the response to chronic imipramine, while mice lacking it still respond to acute imipramine. That supports an acute-versus-chronic distinction for imipramine, not ketamine. The Discussion explicitly says whether ketamine requires this phosphorylation for its behavioral effects remains to be determined; no page number is available in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Some results are derived from secondary analyses of previously conducted studies, so the setting may not be optimal for examining BDNF variations in patients treated with ketamine.

    “some of the results presented are derived from secondary analyses of previously conducted studies [80,83]; therefore, the setting may not be optimal for the objective considered (examining BDNF variations in patients treated with ketamine).”

    From Variations in BDNF and Their Role in the Neurotrophic Antidepressant Mechanisms of Ketamine and Esketamine: A Review (2024) · cites this paper as [80]

    The Discussion mentions ketamine only as a rapid-acting antidepressant and says its dependence on MeCP2 phosphorylation remains undetermined. The Results describe experiments in mice treated with imipramine, not secondary analyses of BDNF variation in patients treated with ketamine. I searched for secondary analyses, BDNF, and ketamine-treated patients; our copy does not address the attributed point. (LLM, conf=0.76)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hutchinson, A. N., Deng, J. V., Cohen, S., & West, A. E.
Affiliations
  • Duke Medical Center (US)
  • Harvard University (US)
Venue
The Journal of Neuroscience
Published
2012-10-10
Volume
32
Issue
41
Pages
14355-14363
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2066854681
Cited by
53
References
55
Citations by year
2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 7 · 2021: 4 · 2020: 3 · 2019: 3 · 2018: 5 · 2017: 4 · 2016: 3 · 2015: 4 · 2014: 8 · 2013: 4 · 2012: 1
FWCI
3.99
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute of Mental Health (F31MH090754, R21MH096310)
  • National Institute on Drug Abuse (R01DA022202)
  • National Institute of General Medical Sciences (T32GM007753)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
MeCP2, chronic antidepressant treatment, imipramine, depression, social defeat stress, nucleus accumbens, lateral habenula, depression-like behavior, gene transcription
MeSH terms
Animals, Antidepressive Agents, Depression, Male, Mice, Inbred C57BL, Mice, Transgenic, Phosphorylation, Serine, Social Environment, Time Factors, Mice, Methyl-CpG-Binding Protein 2, Gene Knock-In Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review